WellSpring Pharma Services (“WellSpring”), announces the addition of Lonnie Barish, MBA, as executive director of business development, and David Watt as technical director, pharma services.
"David and Lonnie both bring extensive industry experience and have outstanding reputations within the industry," said Sam Ricchezza, vice president, business development. “I am excited to have these two outstanding individuals on board to help us continue building upon our leadership position in the global pharmaceutical manufacturing services business.”
Prior to joining WellSpring, Watt brings more than 20 years of pharmaceutical GMP experience in technical definition and evaluation of Contract Development and Manufacturing projects both from provider and client perspectives. He has previously worked at Valeant, Medicis, Patheon and Syntex Pharmaceuticals.
Barish brings more than 20 years of experience in pharmaceutical sales, marketing and business development, and was most recently executive director, North America, at Nuvisan, and Business Development Director at CoreLab Partners and AAIPharma Services Corp.
"We are excited with the additions of these two key appointments to the WellSpring Pharma Services team," said Wendy Shusko, president of WellSpring Pharmaceutical Corp. “Lonnie and David bring a great deal of business development experience and technical knowledge to our company and will no doubt have a tremendous impact on our company as we grow our business."
WellSpring Pharma Services is a leading provider of pharmaceutical contract manufacturing and packaging services for solids, semisolids, and non-sterile liquids. For more information, please visit http://www.wellspringcmo.com.
